2Murray CJL, Lopez AD. Evidence-based health policy -lessons from the Global Burden of Disease Study. Science, 1996; 274: 740~ 743
3Murray CJL, Lopez, eds. The global burden of disease: Acomprehensive assessment of mortality and disability from diseases, injury and risk factors in 1990 and projected to 2020. Cambridge, MA.:Harvard University Press, 1996
4World Development Indicators Database, Worldbank, 2001
5Siafakas NM, Vemeire P, Pride NB, et al. ERS Consensus Statement. Optimal assessment and management of chronic obstructive puhnonary disease (COPD). Eur Respir J, 1995; 8:1398~1420
6ATS statement. Standrads for the diagnosis and care of patients with chronic obstructive puhmonary disease. Am J Respir Crit Care Med, 1995; 152: S77~ S120
7Guidelines for the management of chronic obstructive pulmonary disease. Tbe Thoracic Society of Australia and New Zealand. Modern Medicine of Australia,July 1995; 138:7:132~146
8The COPD guidelines Group of the standards of care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax, 1997; 52: S1~S28
9Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO report . NIH,NHLBI publication, Number 2701, April 2001
10Tan WC, Seale P, Charoenratanakul S, et al. Chronic obstructive puhmonary disease (COPD) prevalence in 12 Asian countries: projections based on the COPD Prevalence Estimation Model. Poster presented at the American Thoracic Society Meeting, May 2001,San Francisco, USA